Intracranial motion during frameless Gamma-Knife stereotactic radiosurgery.

Frameless intracranial displacement intrafraction motion mask-based Gamma-Knife

Journal

Journal of radiosurgery and SBRT
ISSN: 2156-4647
Titre abrégé: J Radiosurg SBRT
Pays: United States
ID NLM: 101565296

Informations de publication

Date de publication:
2020
Historique:
entrez: 19 3 2020
pubmed: 19 3 2020
medline: 19 3 2020
Statut: ppublish

Résumé

The Gamma-Knife radiosurgery (GKRS) (Elekta AB, Stockholm) platform delivers highly conformal and precise radiation; however, intracranial displacement during treatment allows for the potential of a marginal target-miss. Frameless (mask-based) GKRS using the Gamma Knife Icon system monitors nasal tip motion as a surrogate for intracranial motion by tracking an infrared marker using a high-definition motion management (HDMM) system. To date, there is limited data available regarding the incidence and severity of motion and factors that impact intrafraction motion when treating with frameless GKRS. A retrospective study was performed to evaluate patients with brain tumors who were treated with frameless GKRS using the Gamma Knife Icon between May and December 2018. All patients underwent mask-based immobilization using a thermoplastic mask. Data on patient demographics, mask type, use of bite block, and number of treatments received, use of anxiolytics, treatment time, and whether a physics clearance check was performed prior to treatment were collected. For each treatment session, average displacement (mm), maximum displacement (mm) and total treatment time (min) were recorded and logistic regression analyses were performed. Data was collected for 89 consecutive treatments (38 patients). Of these, an anxiolytic was used in 61 treatments and a physics clearance check was performed for 45 treatments. The median average and maximum displacement was 0.60 mm and 1.22 mm, respectively. An average displacement greater than 0.60 mm was seen with Eastern Cooperative Oncology Group performance status (ECOG) > 1, male gender, and malignant tumors (p < 0.05). Anxiolytic use prior to treatment was associated with a significant reduction in average displacement (p < 0.05). Significantly greater odds of observing a maximum displacement over 1.22 mm was seen with patients with ECOG > 1, male gender, and increased treatment time (p < 0.05). Age > 65 and anxiolytic use were associated with a significant reduction in maximum displacement (p < 0.05). Performance of clearance checks and use of bite block use did not impact average or maximum patient displacement. This is the first study to evaluate patient and treatment-related factors that influence intrafraction motion during GKRS with mask-based immobilization through HDMM tracking. Increased intracranial displacement during frameless GKRS was associated with higher ECOG, male gender, increased treatment time and malignant tumors, while anxiolytics were shown to mitigate excessive motion. Radiosurgery teams should consider these patient factors when treating patients with mask immobilization.

Identifiants

pubmed: 32185087
pmc: PMC7065895

Types de publication

Journal Article

Langues

eng

Pagination

277-285

Informations de copyright

© 2020 Old City Publishing, Inc.

Déclaration de conflit d'intérêts

Authors disclosure of potential conflicts of interest: Dr. Trifiletti receives unrelated clinical trial research funding from Novocure and publishing fees from Springer. The remaining authors have nothing to disclose.

Références

Acta Neurochir (Wien). 1980;52(1-2):1-7
pubmed: 6990697
J Korean Med Sci. 2019 Feb 12;34(8):e57
pubmed: 30833881
J Neurosurg. 2018 Dec 1;129(Suppl1):133-139
pubmed: 30544303
PLoS One. 2018 Mar 2;13(3):e0193809
pubmed: 29499061
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):895-902
pubmed: 30170871
Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):306-13
pubmed: 20385456
Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):281-90
pubmed: 20951506
J Clin Neurosci. 2017 Nov;45:48-53
pubmed: 28866073
Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):618-630
pubmed: 30395902
Neurosurgery. 1989 Feb;24(2):151-9
pubmed: 2645538
J Radiosurg SBRT. 2017;4(4):289-301
pubmed: 29296453
Cureus. 2016 Mar 13;8(3):e531
pubmed: 27081592
Prog Neurol Surg. 2019;34:19-27
pubmed: 31096212
Int J Radiat Oncol Biol Phys. 2014 May 1;89(1):206-13
pubmed: 24725703

Auteurs

Danushka S Seneviratne (DS)

Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA.

Laura A Vallow (LA)

Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA.

Austin Hadley (A)

Alaska Cancer Treatment Center, Anchorage, AK, USA.

Timothy D Malouff (TD)

Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA.

William C Stross (WC)

Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA.

Steven Herchko (S)

Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA.

Deanna H Pafundi (DH)

Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA.

Daniel M Trifiletti (DM)

Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA.

Jennifer L Peterson (JL)

Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA.

Classifications MeSH